Back to BL BAUPOST GROUP LLC/MA

CGEMCGEM
8 quarters

Position history for BLBAUPOST GROUP LLC/MA's holdings in CULLINAN THERAPEUTICS INC

No. The Baupost Group exited its CGEM (Cullinan Therapeutics) position in Q4 2022. Its Q3 2022 13F listed 429,646 shares worth $5.5M. The Baupost Group already held CGEM in its Q1 2021 13F, the earliest on record, and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$71.7M

Total Shares Change

-1.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2022-Q4
Latest
Exited
0
-100.0%
$00.0%$10.55
0
2022-Q3
Decreased
429,646
-72.0%
$5.5M0.1%$12.44
0
2022-Q2
Unchanged
1.5M
0.0%
$19.7M0.3%$12.40
0
2022-Q1
Unchanged
1.5M
0.0%
$16.1M0.2%$11.11
0
2021-Q4
Decreased
1.5M
-16.3%
$22.5M0.2%$15.70
0
2021-Q3
Unchanged
1.8M
0.0%
$40.2M0.4%$22.63
0
2021-Q2
Unchanged
1.8M
0.0%
$46.3M0.4%$26.01
0
2021-Q1
New
1.8M
-
$71.7M0.6%$39.73
58

Other major holders of CGEM: BlackRock, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used